PXMD Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2024-03-12 | Weisman Howard J. | director, officer: Chief Executive Officer | 34,748 | F-InKind | D | 2,927 | 0.69 | 2,020.00 |
2024-03-12 | Sheldon Stephen | officer: CFO and COO | 10,137 | F-InKind | D | 3,356 | 0.69 | 2,316.00 |
2024-03-12 | Rome Zachary | director | 10,244 | F-InKind | D | 4,904 | 0.69 | 3,384.00 |
2024-03-12 | LaRochelle Karen | director | 2,225 | F-InKind | D | 604 | 0.69 | 416.80 |
2024-03-12 | Hough David W. | officer: Chief Medical Officer | 5,905 | F-InKind | D | 1,452 | 0.69 | 1,002.00 |
2024-03-12 | Coelho John F | director | 4,408 | F-InKind | D | 207 | 0.69 | 142.80 |
2024-03-12 | CASAMENTO CHARLES J | director | 2,386 | F-InKind | D | 992 | 0.69 | 684.50 |
2024-02-21 | Hough David W. | officer: Chief Medical Officer | 7,357 | F-InKind | D | 291 | 0.66 | 191.80 |
2024-02-21 | Sheldon Stephen | officer: CFO and COO | 13,493 | F-InKind | D | 243 | 0.66 | 160.10 |
2024-01-29 | Rome Zachary | director | 15,148 | S-Sale | D | 811 | 0.48 | 389.30 |
2024-01-29 | LaRochelle Karen | director | 2,829 | S-Sale | D | 78 | 0.48 | 37.44 |
2024-01-29 | Coelho John F | director | 4,615 | S-Sale | D | 27 | 0.48 | 12.96 |
2024-01-29 | CASAMENTO CHARLES J | director | 3,378 | F-InKind | D | 97 | 0.76 | 73.72 |
2024-01-29 | Weisman Howard J. | director, officer: Chief Executive Officer | 37,675 | S-Sale | D | 372 | 0.47 | 174.80 |
2023-11-27 | Coelho John F | director | 4,642 | S-Sale | D | 12 | 1.03 | 12.30 |
2023-11-27 | Weisman Howard J. | director, officer: Chairman and CEO | 38,047 | S-Sale | D | 162 | 1.03 | 166.20 |
2023-11-27 | Derby Michael | 10 percent owner | 25,650 | S-Sale | D | 185 | 1.03 | 189.90 |
2023-11-27 | LaRochelle Karen | director | 2,907 | S-Sale | D | 35 | 1.03 | 35.93 |
2023-11-27 | Rome Zachary | director | 15,959 | S-Sale | D | 359 | 1.03 | 369.90 |
2023-11-20 | Sheldon Stephen | officer: CFO and COO | 13,736 | F-InKind | D | 971 | 1.75 | 1,699.00 |
2023-10-27 | Rome Zachary | director | 277,390 | S-Sale | D | 16,301 | 0.18 | 3,012.00 |
2023-10-27 | Derby Michael | 10 percent owner | 439,171 | S-Sale | D | 9,175 | 0.19 | 1,740.00 |
2023-10-27 | Coelho John F | director | 79,090 | S-Sale | D | 570 | 0.19 | 108.00 |
2023-10-27 | LaRochelle Karen | director | 49,994 | S-Sale | D | 1,679 | 0.19 | 317.30 |
2023-10-27 | Weisman Howard J. | director, officer: Chairman and CEO | 649,549 | S-Sale | D | 8,049 | 0.19 | 1,524.00 |
2023-10-23 | Hough David W. | officer: Chief Medical Officer | 130,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
2023-10-02 | CASAMENTO CHARLES J | director | 59,047 | F-InKind | D | 6,536 | 0.29 | 1,870.00 |
2023-08-28 | Coelho John F | director | 79,683 | S-Sale | D | 774 | 0.52 | 403.50 |
2023-08-29 | Coelho John F | director | 79,660 | S-Sale | D | 23 | 0.49 | 11.18 |
2023-08-28 | Weisman Howard J. | director, officer: Chairman and CEO | 689,729 | S-Sale | D | 12,000 | 0.49 | 5,858.00 |
2023-08-29 | Weisman Howard J. | director, officer: Chairman and CEO | 680,133 | S-Sale | D | 9,596 | 0.48 | 4,650.00 |
2023-08-30 | Weisman Howard J. | director, officer: Chairman and CEO | 657,598 | S-Sale | D | 22,535 | 0.45 | 10,053.00 |
2023-08-28 | LaRochelle Karen | director | 52,129 | S-Sale | D | 2,000 | 0.50 | 1,002.00 |
2023-08-29 | LaRochelle Karen | director | 51,673 | S-Sale | D | 456 | 0.48 | 221.00 |
2023-08-28 | Rome Zachary | director | 307,284 | S-Sale | D | 12,000 | 0.49 | 5,862.00 |
2023-08-29 | Rome Zachary | director | 298,492 | S-Sale | D | 8,792 | 0.48 | 4,257.00 |
2023-08-30 | Rome Zachary | director | 293,691 | S-Sale | D | 4,801 | 0.47 | 2,235.00 |
2023-08-28 | Derby Michael | 10 percent owner | 454,886 | S-Sale | D | 7,000 | 0.49 | 3,452.00 |
2023-08-29 | Derby Michael | 10 percent owner | 448,346 | S-Sale | D | 6,540 | 0.48 | 3,169.00 |
2023-08-21 | Rome Zachary | director | 349,284 | S-Sale | D | 20,000 | 0.58 | 11,626.00 |
2023-08-22 | Rome Zachary | director | 319,284 | S-Sale | D | 30,000 | 0.54 | 16,236.00 |
2023-08-16 | Hough David W. | officer: Chief Medical Officer | 30,000 | D | 0 | 0.00 | 0.00 | |
2023-07-26 | Weisman Howard J. | director, officer: Chief Executive Officer | 701,729 | F-InKind | D | 9,952 | 0.72 | 7,136.00 |
2023-07-26 | Coelho John F | director | 80,457 | F-InKind | D | 389 | 0.72 | 278.90 |
2023-07-26 | Derby Michael | director, officer: Executive Chairman | 461,886 | F-InKind | D | 6,272 | 0.72 | 4,497.00 |
2023-07-26 | LaRochelle Karen | director | 54,129 | F-InKind | D | 1,143 | 0.72 | 819.50 |
2023-07-26 | Rome Zachary | director, officer: Chief Operating Officer | 369,284 | F-InKind | D | 9,584 | 0.72 | 6,872.00 |
2023-04-26 | Rome Zachary | director, officer: Chief Operating Officer | 378,868 | F-InKind | D | 9,584 | 1.61 | 15,430.00 |
2023-04-26 | LaRochelle Karen | director | 55,272 | F-InKind | D | 1,143 | 1.61 | 1,840.00 |
2023-04-26 | Derby Michael | director, 10 percent owner, officer: Executive Chairman | 468,158 | F-InKind | D | 6,272 | 1.61 | 10,098.00 |
2023-04-26 | Weisman Howard J. | director, officer: Chief Executive Officer | 711,681 | F-InKind | D | 9,952 | 1.61 | 16,023.00 |
2023-04-26 | LaRochelle Karen | director | 54,613 | F-InKind | D | 1,802 | 1.61 | 2,901.00 |
2023-04-26 | Coelho John F | director | 80,846 | F-InKind | D | 389 | 1.61 | 626.30 |
2023-04-26 | Rome Zachary | director, officer: Chief Operating Officer | 382,180 | F-InKind | D | 6,272 | 1.61 | 10,098.00 |
2023-04-13 | Weisman Howard J. | director, officer: Chief Executive Officer | 721,633 | A-Award | A | 180,000 | 0.00 | 0.00 |
2023-04-13 | Sheldon Stephen | officer: Chief Financial Officer | 250,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
2023-04-13 | Rome Zachary | director, officer: Chief Operating Officer | 388,452 | A-Award | A | 100,000 | 0.00 | 0.00 |
2023-04-13 | LaRochelle Karen | director | 56,415 | A-Award | A | 14,000 | 0.00 | 0.00 |
2023-04-13 | Derby Michael | director, 10 percent owner, officer: Executive Chairman | 474,430 | A-Award | A | 150,000 | 0.00 | 0.00 |
2023-04-13 | Coelho John F | director | 81,235 | A-Award | A | 14,000 | 0.00 | 0.00 |
2023-04-13 | CASAMENTO CHARLES J | director | 65,583 | A-Award | A | 14,000 | 0.00 | 0.00 |
2023-03-08 | Weisman Howard J. | director, officer: Chief Executive Officer | 545,128 | S-Sale | D | 32,397 | 1.46 | 47,300.00 |
2023-03-09 | Weisman Howard J. | director, officer: Chief Executive Officer | 541,633 | S-Sale | D | 3,495 | 1.44 | 5,033.00 |
2023-03-08 | Rome Zachary | director, officer: Chief Operating Officer | 291,823 | S-Sale | D | 30,034 | 1.47 | 44,150.00 |
2023-03-09 | Rome Zachary | director, officer: Chief Operating Officer | 288,452 | S-Sale | D | 3,371 | 1.44 | 4,854.00 |
2023-03-09 | Derby Michael | director, 10 percent owner, officer: Executive Chairman | 324,430 | S-Sale | D | 2,143 | 1.43 | 3,064.00 |
2023-03-09 | LaRochelle Karen | director | 42,415 | S-Sale | D | 335 | 1.48 | 495.80 |
2023-03-09 | Coelho John F | director | 67,235 | S-Sale | D | 130 | 1.48 | 192.40 |
2023-03-06 | Weisman Howard J. | director, officer: Chief Executive Officer | 601,076 | S-Sale | D | 13,589 | 1.72 | 23,373.00 |
2023-03-07 | Weisman Howard J. | director, officer: Chief Executive Officer | 577,525 | S-Sale | D | 23,551 | 1.53 | 36,033.00 |
2023-03-06 | Rome Zachary | director, officer: Chief Operating Officer | 345,289 | S-Sale | D | 13,560 | 1.72 | 23,323.00 |
2023-03-07 | Rome Zachary | director, officer: Chief Operating Officer | 321,857 | S-Sale | D | 23,432 | 1.53 | 35,851.00 |
2023-03-06 | Derby Michael | director, 10 percent owner, officer: Executive Chairman | 341,707 | S-Sale | D | 13,828 | 1.72 | 23,784.00 |
2023-03-07 | Derby Michael | director, 10 percent owner, officer: Executive Chairman | 326,573 | S-Sale | D | 15,134 | 1.55 | 23,458.00 |
2023-03-02 | Coelho John F | director | 67,365 | S-Sale | D | 3,013 | 1.93 | 5,815.00 |
2023-03-02 | LaRochelle Karen | director | 43,847 | S-Sale | D | 7,736 | 1.94 | 15,008.00 |
2023-03-03 | LaRochelle Karen | director | 42,750 | S-Sale | D | 1,097 | 1.90 | 2,084.00 |
2023-03-02 | Weisman Howard J. | director, officer: Chief Executive Officer | 629,988 | S-Sale | D | 11,679 | 1.94 | 22,657.00 |
2023-03-03 | Weisman Howard J. | director, officer: Chief Executive Officer | 614,665 | S-Sale | D | 15,323 | 1.90 | 29,114.00 |
2023-03-02 | Rome Zachary | director, officer: Chief Operating Officer | 372,048 | S-Sale | D | 12,952 | 1.94 | 25,127.00 |
2023-03-03 | Rome Zachary | director, officer: Chief Operating Officer | 358,849 | S-Sale | D | 13,199 | 1.89 | 24,946.00 |
2023-03-02 | Derby Michael | director, 10 percent owner, officer: Executive Chairman | 374,503 | S-Sale | D | 10,497 | 1.94 | 20,364.00 |
2023-03-03 | Derby Michael | director, 10 percent owner, officer: Executive Chairman | 355,535 | S-Sale | D | 18,968 | 1.90 | 36,039.00 |
2022-11-19 | Sheldon Stephen | officer: Chief Financial Officer | 150,000 | A-Award | A | 135,000 | 0.00 | 0.00 |
2022-08-12 | Sheldon Stephen | officer: Chief Financial Officer | 18,799 | I | 0 | 0.00 | 0.00 | |
2022-08-12 | Sheldon Stephen | officer: Chief Financial Officer | 15,000 | D | 0 | 0.00 | 0.00 | |
2020-11-06 | Sheldon Stephen | officer: Chief Financial Officer | 0 | I | 17,090 | 3.00 | 51,270.00 | |
2022-08-12 | LaRochelle Karen | director | 51,583 | D | 0 | 0.00 | 0.00 | |
2022-08-12 | Derby Michael | director, 10 percent owner, officer: Executive Chairman | 7,241,745 | I | 0 | 0.00 | 0.00 | |
2022-08-12 | Derby Michael | director, 10 percent owner, officer: Executive Chairman | 385,000 | D | 0 | 0.00 | 0.00 | |
2022-08-12 | Rome Zachary | director, officer: Chief Operating Officer | 385,000 | D | 0 | 0.00 | 0.00 | |
2022-08-12 | Weisman Howard J. | director, officer: Chief Executive Officer | 641,667 | D | 0 | 0.00 | 0.00 | |
2022-08-12 | Coelho John F | director | 70,378 | D | 0 | 0.00 | 0.00 | |
2020-11-06 | Coelho John F | director | 0 | D | 17,086 | 3.00 | 51,258.00 | |
2022-10-01 | CASAMENTO CHARLES J | director | 51,583 | A-Award | A | 51,583 | 0.00 | 0.00 |
2022-08-30 | TardiMed Sciences LLC | director: | 7,336,745 | P-Purchase | A | 95,000 | 5.25 | 498,750.00 |
2022-08-30 | Derby Michael | officer: Executive Chairman | 7,336,745 | P-Purchase | A | 95,000 | 5.25 | 498,750.00 |
2022-08-12 | TardiMed Sciences LLC | 10 percent owner | 7,241,745 | D | 0 | 0.00 | 0.00 | |
2022-08-12 | Weisman Howard J. | director, officer: Chief Executive Officer | 601,667 | D | 0 | 0.00 | 0.00 | |
2022-08-12 | Sheldon Stephen | officer: Chief Financial Officer | 25,000 | D | 0 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.